Rare AstraZeneca 7 year 4x oversubscribed
AstraZeneca, the Anglo-Swedish pharmaceutical company, priced a €750m seven year bond on Wednesday. It was four times oversubscribed and priced somewhere near the middle of the broad range suggested by the bonds of its peers.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
